Curcumin and curcumin derivatives inhibit Tat-mediated transactivation of type 1 human immunodeficiency virus long terminal repeat

Research in Virology

Volumn 149, Issue 1, 1998, Pages 43-52

  Barthelemy, S ^a   Vergnes, L ^a   Moynier, M ^a   Guyot, D ^a   Labidalle, S ^a   Bahraoui, E ^a  

^a UNIVERSITÉ DE TOULOUSE   (France)

Author keywords

Curcumin; Derivatives; HIV1; Inhibition; Superoxide; Tat protein; Transactivation

Indexed keywords

CURCUMIN; SUPEROXIDE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIINFLAMMATORY ACTIVITY; ANTIVIRAL ACTIVITY; ARTICLE; GENE EXPRESSION REGULATION; GROWTH INHIBITION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LONG TERMINAL REPEAT; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN SECRETION; REGULATOR GENE; TRANSACTIVATION; VIRUS INHIBITION; VIRUS TRANSCRIPTION;

EID: 0031976901     PISSN: 09232516     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0923-2516(97)86899-9     Document Type: Article

References (36)

1. Brouet, I. & Ohshima, H. (1995), Curcumin, an antitumor promoter and anti-inflammatory agent, inhibits induction of nitric-oxide synthase in activated macrophages. Biochem. Biophys. Res. Commun., Vol, 533-540.
2. Buonaguro, L., Barillari, G., Chang, H.K., Bohan, C.A., Kao, V., Morgan, R., Gallo, R.C. & Ensoli, B. (1992), Effects of the HIV-1 Tat protein on the expression of inflammatory cytokines. J. Virol., 66, 7159-7167.
3. Buonaguro, L., Buonaguro, F.M., Giraldo, G. & Ensoli, B. (1994), The HIV-1 Tat protein transactivates tumor necrosis beta gene expression through a TAR-like structure. J. Virol., 68, 2677-2682.
4. Chan, M.M. (1995), Inhibition of tumor necrosis factor by curcumin, a phytochemical. Biochem. Pharm., 49, 1551-1556.
5. Charneau, P., Alizon, M. & Clavel, F. (1992), A second origin of DNA plus-strand synthesis is required for optimal HIV replication. J. Virol., 66, 2814-2820.
6. Demarchi, F., Adda di Fagagna, F., Falaschi, A. & Giacca, M. (1996), Activation of transcription factor NF-κB by Tat protein of HIV-1. J. Virol., 70, 4427-4437.
7. Dröge, W., Eck, H.P. & Mohm, S. (1992), HIV-induced cysteine deficiency and T-cell dysfunction - a rationale for treatment with N-acetylcysteine. Immunol Today, 13, 211-214.
8. Gaynor, R.B. (1995), Regulation of HIV-1 gene expression by the transactivation protein Tat. Curr. Top. Microbiol. Immunol., 193, 51-77.
9. Halliwell, B. (1994), Free-radicals, antioxidants, and human-disease - curiosity, cause, or consequence. Lancet, 344, 721-724.
10. Haubert, J., Perkins, A., Heimer, E.P. & Cullen, B.R. (1987), Transactivation of human immunodeficiency virus gene expression is mediated by nuclear events. Proc. Natl. Acad. Sci. USA, 84, 6367-6368.
11. Hyland, K., Voisin, E., Banoun, H. & Auclair, C. (1983), Superoxide dismutase assay using alkine dimethylsulfoxide as superoxide anion-generating system. Anal. Biochem., 135, 280-287.
12. Jacobson, E.J., Vandoornik, F.J., Ayer, D.E., Belonga, K.L., Braughler, J.M., Hall, E.D. & Houser, D.J. (1992), 2-(Aminomethyl)chromans that inhibit irondependent peroxidation and protect against central nervous system trauma and ischemia. J. Med. Chem., 35, 4464-4472.
13. Jiang, M.C., Lin, J.K. & Chen, S.S.L. (1996), Inhibition of HIV-1 Tat-mediated transactivation by quinacrine and chloroquine. Biochem. Biophys. Res. Commun., 226, 1-7.
14. Jones, K.A. (1993), Tat and HIV-1 promoter. Cur. Opin. Cell Biol. 5, 461-468.
15. Kunchandy, E. & Rao, M.N.A. (1990), Oxygen radical scavenging activity of curcumin. Int. J. Pharm., 58, 237-240.
16. Kurata, S.I. (1996), Sensitization of the HIV-1-LTR upon long-term low-dose oxidative stress. J. Biol. Chem., 271, 21798-21802.
17. Li, C.J., Zhang, L.J., Dezube, B.J., Crumpacker, C.S. & Pardee, A.B. (1993), Three inhibitors of HIV-1 long terminal repeat-directed gene expression and virus replication. Proc. Natl. Acad. Sci. USA. 90, 1839-1842.
18. Liu, J., Perkins, N.D., Schmid, R.M. & Nabel, G.J. (1992), Specific NF-κB subunits act in concert with Tat to stimulate HIV-1 transcription. J. Virol., 66, 3883-3887.
19. Loupy, A., Sansoulet, J. & Varizi, F. (1987), Améliorations et simplifications de la synthèse des éthers phénoliques par alkylation d'ions phénates: catalyse par transfert de phase solide-liquide sans solvant. Bul. Soc. Chim. Fr., 6, 1027-1035.
20. Mallery, S.R., Bailer, R.T., Hohl, C.M., Ng-Bautista, C.L., Ness, G.M., Livingston, B.E., Hout, B.L., Stephens, R.E. & Brierley, G.P. (1995), Cultured AIDS-related Kaposi's sarcoma (AIDS-KS) cells demonstrate impaired bioenergetic adaptation to oxidant challenge: implication for oxidant stress in AIDS-KS pathogenesis. J. Cell. Biochem., 59, 317-328.
21. Mazumder, A., Raghavan, K., Weinstein, J., Kohn, K.W. & Pommier, Y. (1995), Inhibition of HIV-1 integrase by curcumin. Biochem. Pharm., 49, 1165-1170.
22. Pace, G.W. & Leaf, C.D. (1995), The role of oxidative stress in HIV disease. Free Radical Biol. Med., 19, 523-528.
23. Ranjbar, S. & Holmes, H. (1996), Influence of hydrogen peroxide on the in vitro infectivity of HIV. Free Radical Biol. Med., 20, 573-577.
24. Reddy, A.C. & Lokesh, B.R. (1994), Studies on the inhibitory effects of curcumin and eugenol on the formation of reactive oxygen species and the oxidation of ferrous iron. Mol. Cell. Biochem., 137, 1-8.
25. Robert-Guroff, M., Popovic, M., Gartner, S., Markham, P., Gallo, R.C. & Reitz, M.S. (1990), Structure and expression of Tat-, rev-, and nef-specific transcripts of human immunodeficiency virus type-1-infected lymphocytes and macrophages. J. Virol., 64, 3391-3398.
26. Rocancourt, D., Bonneret, C., Jouin, H., Emerman, M. & Nicolas, J.F. (1990), Activation of a β-galactosidase recombinant provirus : application to titration of HIV and HIV-infected cells. J. Virol., 64, 2660-2668.
27. Rosenblatt, J.D., Miles, S., Gasson, J.C. & Prager, D. (1995), Transactivation of cellular genes by human retroviruses. Curr. Top. Microbiol. Immunol., 193, 25-49.
28. Schreck, R., Albermann, K. & Baeuerle, A. (1992), Nuclear factor κB: an oxidative stress-responsive transcription factor of eukaryotic cells (a review). Free Radical Res. Commun., 17, 221-237.
29. Schreck, R., Rieber, P. & Baeuerle, A. (1991), Reactive oxygen intermediates as apparently widely used messenger in the activation of NFR-Kappa-B transcription factor and HIV-1. Embo J., 10, 2247-2258.
30. Schwarz, K.B. (1996), Oxidative stress during viral infection: a review. Free Radical Biol. Med., 21, 641-649.
31. Singh, S. & Aggarwal, B.B. (1995), Activation of transcription factor NF-κB is suppressed by curcumin (diferuloylmethane). J. Biol. Chem., 270, 24995-25000.
32. Staal, F., Roederer, M., Israelski, D.M., Bupp, J., Mole, L.A., McShane, D., Deresinski, S.C., Ross, W., Sussman, H., Raju, P.A., Anderson, M.T., Moore, W., Ela, S.W., Herzenberg, L.A. & Herzenberg, L.A. (1992), Intracellular glutathione levels in T-cell subsets decrease in HIV-infected individuals. AIDS Res. Hum. Retroviruses, 8, 305-311.
33. Sui, Z., Salto, R., Li, J., Craik, C. & Ortiz de Montellano, P.R. (1993), Inhibition of the HIV-1 and HIV-2 proteases by curcumin and curcumin boron complexes. Bioorg. Med. Chem., 1, 415-422.
34. Vives, E., Charneau, P., Van Rietschoten, J., Rochat, H. & Bahraoui, E. (1994), Effects of the Tat basic domain on HIV-1 transactivation, using chemically synthesized Tat protein and Tat peptides. J. Virol., 68, 3343-3353.
35. Westendorp, M., Shatrov, V.A., Schulze-Osihoff, K., Frank, R., Kraft, M., Los, M., Krammer, P.H., Droöge, W. & Lehmann, V. (1995), HIV-1 Tat potentiates TNF-induced NF-κB activation and cytotoxicity by altering the cellular redox state. EMBO J., 14, 546-554.
36. +) hematopoietic progenitors in human immunodeficiency virus-1-seropositive thrombocytopenic individuals. Blood, 80, 3036-3043.